Several groundbreaking solutions are now available in the Britain for treating diabetes type 2 . Saxenda, Metformin, and Mounjaro represent different approaches, with Wegovy and Mounjaro being injectable incretin receptor activators primarily aimed at weight management alongside blood sugar contr